The global aromatic chemicals market will reach 8.41 billion US dollars

ACI expects healthcare antiseptic manufacturers to lose most active ingredients
The US Food and Drug Administration (FDA) will ban some 80% of active ingredients currently allowed for use in healthcare antiseptics, the American Cleaning Institute (ACI) expects.
Plans to require manufacturers to submit data demonstrating the safety and efficacy of their antibacterial ingredients were set out in a 2015 proposed rule - and are expected to become law when the final rule is issued. The FDA will assess data submitted by industry and decide whether to classify actives as "generally recognised as safe and effective" (Gras/Grae), or ban their use in the products.
Triclosana href='https://www.echemi.com/products/pid_Seven3714-triclocarban.html'>Triclocarban.
ACI expects triclosan to face a ban in healthcare products as well, along with more than 20 other ingredients, its associate vice president for environmental safety, Paul DeLeo, told CW+BiocidesHub.
Some substances will be banned due to a lack of support by industry, he said. "Companies know it won't get FDA approval so they are not willing to do the additional testing the agency is requiring."
Others will fail because the data to support them is too challenging to generate. The agency, he says, is asking for "new methods that we are not aware of anyone having successfully completed in this space", but it has been willing to give companies more time.
Looking for chemical products? Let suppliers reach out to you!
2026-07-20
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Henkel to Acquire Olaplex in $1.4 Billion Deal
-
Lubrizol Announces Elimination of PFAS from Its Peptide Synthesis Process
-
Taekwang Group Establishes SIL Cosmetics Division, Targeting the Korean and Global Markets
-
DKSH to Distribute Point Grey’s Baby and Personal Care Portfolio in Vietnam
-
DKSH to Distribute Exsymol's Silanols, Peptides, and Natural Active Ingredients in South Korea
-
Kering and L'Oréal Form $4 Billion Strategic Alliance in Luxury Beauty and Wellness
-
End of an Era: KDC/One to Close 150-Year-Old Somerset Cosmetics Factory as Production Shifts to Scotland
-
FDA approves bemotrizinol, a long-used UV filter, for U.S. sunscreens
-
Givaudan to Build New Fragrance Compounding Facility in Pedro Escobedo, Mexico
-
Univar Solutions Expands Partnership with American Distilling in EMEA to Strengthen Natural Specialty Ingredients Distribution Network
Recommend Reading
-
Givaudan Breaks Ground on New Fragrance Factory in Guangzhou
-
Nouryon Opens New Customer Experience and Innovation Center in Brazil
-
Elkem Launches Innovative Formulations with Low-Cyclic Silicone Ingredients
-
HARKE GROUP Acquires Vendico Group, Strengthening Nordic Market leadership
-
Nouryon's Production Facilities in China Have Obtained Halal Certification for Personal Care Ingredients
-
Port inventory rises, November ethylene glycol price center shifts downward
-
Insufficient Spot Buying Interest, Acrylonitrile Market Slips Again in China
-
Cost Support: Styrene-butadiene rubber market prices rise sharply
-
China's Soda Ash Market Remains Stable
-
BASF Partners with Andritz for Carbon Capture Project in Aarhus